Djasur Yuldashev | Neutron Capture Therapy | Innovative Research Award

Published on by Applied Scientist

Innovative Research Award

Djasur Yuldashev
Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan

Djasur Yuldashev
Affiliation Bukhara State Medical Institute named after Abu Ali ibn Sino
Country Uzbekistan
Scopus ID 57444541800
Documents 4
Citations 6
h-index 2
Subject Area Neutron Capture Therapy
Event Applied Scientist
ORCID 0000-0001-9926-1777

Djasur Yuldashev is affiliated with the Bukhara State Medical Institute named after Abu Ali ibn Sino, Uzbekistan. His scholarly activities focus on Neutron Capture Therapy, an interdisciplinary field integrating medical sciences, oncology, radiation technologies, and targeted therapeutic approaches. Based on indexed scholarly publications and citation metrics, his academic profile demonstrates emerging contributions to biomedical research and translational medical science.[1] The Innovative Research Award recognizes researchers whose work advances scientific knowledge through original investigations, methodological development, and measurable academic impact.[1]

Abstract

This academic profile summarizes the research activities of Djasur Yuldashev within the field of Neutron Capture Therapy and related biomedical sciences. His publications contribute to the understanding of advanced therapeutic methodologies, radiation-based treatment strategies, and interdisciplinary medical research. Although representing an early-stage publication portfolio, the available citation record indicates growing scholarly recognition and engagement within the scientific community.[1][2]

Keywords

Neutron Capture Therapy, Oncology, Radiation Medicine, Medical Physics, Biomedical Research, Cancer Therapy, Translational Medicine, Scientific Innovation, Clinical Research, Innovative Research Award

Introduction

Neutron Capture Therapy is an emerging precision treatment strategy that combines targeted drug delivery with neutron irradiation to selectively destroy malignant cells while minimizing damage to healthy tissue.[3] Researchers working in this multidisciplinary field contribute to developments spanning oncology, medical imaging, nuclear medicine, radiation biology, and therapeutic innovation. Academic recognition in this discipline emphasizes scientific rigor, originality, and translational potential.

Research Profile

According to indexed scholarly records, Djasur Yuldashev has authored four Scopus-indexed publications with six citations and an h-index of two.[1] His work reflects continuing engagement in biomedical investigations involving neutron-based therapeutic applications, clinical research methodologies, and interdisciplinary healthcare innovation. The integration of medical science with advanced radiation technologies represents a significant aspect of his academic specialization.

Research Contributions

The research contributions associated with Djasur Yuldashev emphasize evidence-based medical investigation and collaborative scientific research. His studies contribute toward improving therapeutic understanding through clinical evaluation, radiation treatment concepts, and modern oncological approaches.[2]

  • Research in Neutron Capture Therapy.
  • Interdisciplinary biomedical investigations.
  • Radiation medicine and oncology research.
  • Support for translational medical science.

Publications

The researcher’s indexed publication record demonstrates scholarly participation in peer-reviewed scientific literature. Publications focus primarily on medical sciences and neutron-based therapeutic applications. Representative scientific literature within the field includes peer-reviewed studies published with DOI registration, supporting reproducibility and scholarly accessibility.[4]

Research Impact

Research impact may be evaluated through publication productivity, citation activity, interdisciplinary collaboration, and contribution to advancing clinical knowledge. While citation indicators represent only one dimension of scholarly influence, they provide measurable evidence of scientific visibility within the academic community.[1] Continued publication and collaboration are expected to further strengthen future research impact.

Award Suitability

The Innovative Research Award acknowledges researchers demonstrating originality, scientific integrity, and meaningful scholarly contribution. Djasur Yuldashev’s academic activities in Neutron Capture Therapy align with the interdisciplinary objectives of the award by supporting innovation in healthcare research, evidence-based medicine, and emerging therapeutic technologies.[5]

Conclusion

Djasur Yuldashev represents an emerging academic researcher whose work contributes to the advancement of Neutron Capture Therapy and modern biomedical science. Through indexed publications, measurable citation activity, and interdisciplinary medical research, his academic profile reflects continued scientific development consistent with the objectives of scholarly recognition programs such as the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus author details: Djasur Yuldashev, Author ID 57444541800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57444541800
  2. AA Kim, DO Yuldashev, & et al. (2024). Evaluation of the effect of self-shielding on the absorbed dose in NCT.
    https://pubs.aip.org/aip/acp/article-abstract/3020/1/060002/3261349
  3. G Abdullaeva, D Yuldashev, & et al. (2026). Determination of the absorbed dose of epithermal neutrons in a phantom object filled with water.
    https://www.sciencedirect.com/science/article/pii/S1738573326003487
  4. JO Yuldashev. (2026). KETMA-KET VA PARALLEL ULASH: EKVIVALENT QARSHILIKNI TOPISH VA DIAGNOSTIK SXEMALARDA QO ‘LLANILISHI.
    https://cyberleninka.ru/article/
  5. AF Nebesny, DO Yuldashev & et al. (2022). Calculation of radiation dose enhancement by gadolinium compounds for radiation therapy.
    https://iopscience.iop.org/article/10.1088/1742-6596/2155/1/012030/

“`

Moyed Alsaadawe | Oncology | Innovative Research Award

Published on by Applied Scientist

Innovative Research Award

Moyed Alsaadawe
Southern Medical University, Iraq

Moyed Alsaadawe
Affiliation Southern Medical University
Country Iraq
Scopus ID 57208672195
Documents 12
Citations 407
h-index 6
Subject Area Oncology
Event Applied Scientist Awards
ORCID 0000-0001-5594-5480

Moyed Alsaadawe is a PhD student candidate at Southern Medical University with research interests spanning molecular biology, genetics, cell biology, virology, oncology, and biochemistry. His scholarly activities emphasize the molecular mechanisms of disease, viral pathogenesis, and cancer development. His publication record includes investigations into the relationship between viral infections and malignancy, reflecting an interdisciplinary approach to biomedical science.[1]

Abstract

Moyed Alsaadawe in relation to the Innovative Research Award. His work integrates molecular biology, genetics, virology, and oncology with an emphasis on understanding disease mechanisms and cancer development. His published research demonstrates interest in translational biomedical science and interdisciplinary collaboration while contributing to contemporary discussions concerning virus-associated malignancies.[2]

Keywords

Cell Biology; Molecular Biology; Genetics; Oncology; Virology; Biochemistry; Cancer Biology; Epstein–Barr Virus; COVID-19; Translational Medicine.

Introduction

Research at the interface of molecular biology and oncology has become increasingly important for understanding cancer initiation, progression, and therapeutic intervention. Investigations involving viral infections, immune responses, and genetic regulation provide valuable insights into disease mechanisms. Dr. Alsaadawe’s academic interests align with these contemporary scientific priorities through studies emphasizing molecular pathways and virus-associated cancers.[3]

Research Profile

Moyed Alsaadawe is affiliated with Southern Medical University and has developed a research profile centered on molecular mechanisms underlying disease. His interests encompass cell biology, virology, molecular genetics, oncology, and biochemical pathways. According to the supplied publication metrics, his scholarly record includes 12 indexed documents, 407 citations, and an h-index of 6, indicating measurable academic engagement within biomedical research.[1]

Research Contributions

  • Investigation of molecular mechanisms associated with cancer biology.
  • Research on virology and virus-associated malignancies.
  • Integration of molecular biology and genetics into translational biomedical research.
  • Contribution to interdisciplinary oncology research concerning Epstein–Barr virus and COVID-19.

Publications

  • From Viral Infection to Malignancy: The Dual Threat of EBV and COVID-19 in Cancer Development.
    Viruses, published 30 August 2025.

Research Impact

The available publication metrics indicate continued scholarly activity in biomedical sciences with research outputs addressing clinically relevant molecular mechanisms. Citation performance reflects recognition of published work within the scientific community while ongoing doctoral research may contribute further to the understanding of cancer biology and infectious disease interactions.[4]

Award Suitability

Moyed Alsaadawe demonstrates characteristics commonly considered during evaluations for research recognition. Suitability for the Innovative Research Award would ultimately depend upon the formal assessment criteria established by the Applied Scientist Awards committee, including originality, scientific quality, research impact, and eligibility requirements.[5]

Conclusion

Moyed Alsaadawe’s academic activities illustrate an interdisciplinary focus on molecular biology, virology, genetics, and oncology. His published research concerning virus-associated cancer development contributes to ongoing scientific discussions in biomedical research. Continued investigation in these areas may further strengthen his scholarly profile and support future research collaborations and recognition.

References

  1. Elsevier. (n.d.). Scopus author details: Dr. Moyed Alsaadawe, Author ID 57208672195. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57208672195
  2. Moyed Alsaadawe., et al. (2025). Microbiome-Driven Precision Nutrition in Metabolic Syndrome.
    https://link.springer.com/chapter/10.1007/978-981-96-6246-3_13
  3. Moyed Alsaadawe., et al. (2025). From Viral Infection to Malignancy: The Dual Threat of EBV and COVID-19 in Cancer Development.
    https://www.mdpi.com/1999-4915/17/9/1195
  4. Moyed Alsaadawe., et al. (2019). Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS.
    https://www.sciencedirect.com/science/article/abs/pii/S0006291X19306618
  5. Moyed Alsaadawe., et al. (2022). Prevalence and seasonal pattern of enteric viruses among hospitalized children with acute gastroenteritis in Samawah, Iraq.
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8852632/